I wonder if I might be allowed to comment on the paper by Stenkvist et al.1 in the October issue of your journal?
The paper analyses the reproducibility of subjective grading systems for breast carcinoma, using those of WHO2 3 and the one I published in 1971. It is obvious that a great deal of work has gone into the paper, both at the microscope and on computer level. However, some points need to be raised concerning the use of the latter typing system. Firstly, Stenkvist et al., describing their use of the system, note that each factor was examined at a magnification of 400. Reference to my paper will show that it was essential that the tumours were 'classified from groups of cells that stood out on low power as cells nearest to the type seen in tumours recurring 10 years or more after operation, irrespective of the findings elsewhere on the slide'. It is to these cells that the criteria apply; that is to say, one must first select a field on low power before the criteria can be studied on high power. When the cells are not in groups they do not express their characteristic morphology (see Table III These specifications have been adopted universally as a means of attaining good inter and intra laboratory comparability of haemoglobin. The ICSH protocol specifies that the preparation must be dispensed in sealed 10 ml ampoules of amber glass under sterile conditions. There are valid reasons for this requirement,
